MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

GLP-1(28-36)amide

CAS No. : 1225021-13-5

MCE 站：GLP-1(28-36)amide

产品活性：GLP-1(28-36)amide 是一段 GLP-1 的 C-端九肽，是一种中性内肽酶 (NEP) 裂解 GLP-1 的主要产物。GLP-1(28-36)amide 是一种抗氧化剂，靶向线粒体，抑制线粒体通透性转变 (MPT)。GLP-1(28-36)amide 具有抗糖尿病和心脏保护作用。

研究领域：GPCR/G Protein

作用靶点：Glucagon Receptor

In Vitro: Different from DPP-IV, NEP, which cleaves GLP-1(7-36)amide or GLP-1(9-36)amide to generate GLP-1(28-36)amide, is widely distributed in endothelial cells, vascular smooth muscle cells, cardiac cells ａnd renal epithelial cells.
GLP-1(28-36)amide (100 nM) treatment on hepatocytes for 24 hours directly modulates mitochondrial oxidative metabolism, such as gluconeogenesis in mitochondria of hepatocytes.
The plasma half-life of GLP-1(28-36)amide is longer in human hepatocytes (t_1/2 = 24 min) than that in mouse hepatocytes (t_1/2 = 13 min).

In Vivo: The administration of GLP-1(28-36)amide at a rate of 18.5 nmol/kg BW/day for 9 weeks to diet-induced obese mice diminishes the development of hepatic steatosis.
The intraperitoneal injection of 18 nmol/kg GLP-1(28-36)amide once daily for 9 weeks show cytoprotective effect on pancreatic β cells by increasing mass ａnd promoting proliferation in a β-cell injury diabetic mouse model.
An in vivo study in high-fat diet-fed mice indicates that a six-week administration of 18.5 nmol/kg GLP-1(28-36)amide improved hepatic glucose disposal, which is associated with increased cAMP levels ａnd phosphorylation of PKA target.
Administered GLP-1(28-36)amide for 20 min to male C57BL6/J mice (10-12 week old), then isolated hearts underwent 30 min of global ischemia ａnd 40 min of reperfusion, the recovery of left ventricular developed pressure (LVDP) is significantly greater in GLP-1(28-36)amide group compared to vehicle-treated hearts.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Diabetes Related Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Exendin-4  |  Liraglutide  |  Glucagon (1-29), bovine, human, porcine  |  Avexitide  |  Adomeglivant  |  GLP-1(7-37)  |  GLP-1(7-36), amide acetate  |  BETP  |  GLP-2(1-33)(human)  |  GRA Ex-25  |  Cotadutide acetate  |  Glucagon-like peptide 1 (1-37), human TFA  |  NNC-0640  |  Taspoglutide  |  GLP-1 moiety from Dulaglutide  |  Glucagon receptor antagonists-2  |  Exendin-3/4 (59-86)  |  FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS  |  GLP-1(32-36)amide  |  GLP-1(9-36)amide  |  Glucagon receptor antagonists-1  |  GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS  |  HAEGTFT  |  HAEGTFTSD  |  HAEGTFTSDVS

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。